Starsource Multitrade

Starsource Multitrade Equity Ratio

The Equity Ratio of Starsource Multitrade (506365.BO) as of Oct 20, 2026 is 71.18 %. In the previous year, Equity Ratio was 98.46 % — a change of -27.71% (lower).

Equity Ratio

71.18 %

YoY

-27.71%

Last updated:

Equity Ratio of Starsource Multitrade is 2026 71.18 % . Equity Ratio of Starsource Multitrade was 2025 98.46 % . It decreases by -27.71% lower compared to the previous year.

The Starsource Multitrade Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
99.12 INR
Jan 1, 2020
97.98 INR
Jan 1, 2021
99.47 INR
Jan 1, 2022
99.07 INR
Jan 1, 2023
99.83 INR
Jan 1, 2024
98.37 INR
Jan 1, 2025
98.46 INR
Jan 1, 2026
71.18 INR
The Starsource Multitrade Equity Ratio history
YEAREquity RatioYoY
71.18 %-27.71%
98.46 %+0.10%
98.37 %-1.47%
99.83 %+0.76%
99.07 %-0.40%
99.47 %+1.52%
97.98 %-1.15%
99.12 %+0.43%
98.70 %+5.56%
93.50 %-1.52%
94.94 %+3.37%
91.84 %-1.55%
93.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Equity Ratio of Starsource Multitrade is 71.18 % in 2026.

Equity Ratio of Starsource Multitrade changed from 98.46 % to 71.18 %, representing a -27.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Starsource Multitrade

All Key Metrics — Starsource Multitrade